We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Weighs Lilly, Amgen Findings On Cancer Drugs

Law360 (December 12, 2008, 12:00 AM EST) -- The U.S. Food and Drug Administration has asked an advisory committee to consider whether clinical studies by Amgen Inc. and ImClone Systems Inc. are strong enough to show that their respective...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.